Mei Wang

1.3k total citations
64 papers, 900 citations indexed

About

Mei Wang is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Mei Wang has authored 64 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Physiology. Recurrent topics in Mei Wang's work include Angiogenesis and VEGF in Cancer (6 papers), Glioma Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (5 papers). Mei Wang is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Glioma Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (5 papers). Mei Wang collaborates with scholars based in China, United States and Australia. Mei Wang's co-authors include Xian Gu, Zefen Xiao, Wei Yin, Xiaodong Jiang, Jung Tak Park, Mitsuo Kato, Rama Natarajan, Hang Yuan, Linda Lanting and Nancy Castro and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mei Wang

61 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Wang China 15 418 263 201 200 111 64 900
Leye He China 21 561 1.3× 203 0.8× 142 0.7× 253 1.3× 240 2.2× 67 1.1k
Wanfu Xu China 21 706 1.7× 242 0.9× 143 0.7× 386 1.9× 263 2.4× 60 1.3k
Long Wang China 25 680 1.6× 328 1.2× 222 1.1× 471 2.4× 191 1.7× 83 1.5k
Yih‐Jer Wu Taiwan 20 545 1.3× 102 0.4× 201 1.0× 114 0.6× 68 0.6× 88 1.3k
Xinbo Wang China 19 451 1.1× 319 1.2× 194 1.0× 227 1.1× 229 2.1× 101 1.1k
M. Yamashita Japan 19 437 1.0× 167 0.6× 169 0.8× 86 0.4× 44 0.4× 57 959

Countries citing papers authored by Mei Wang

Since Specialization
Citations

This map shows the geographic impact of Mei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Wang more than expected).

Fields of papers citing papers by Mei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Wang. The network helps show where Mei Wang may publish in the future.

Co-authorship network of co-authors of Mei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Wang. A scholar is included among the top collaborators of Mei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Wang. Mei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Fang, Xin Jiang, Xuyu Chen, et al.. (2025). Identification of differentially expressed genes associated with ferroptosis in ulcerative colitis. PLoS ONE. 20(7). e0327990–e0327990. 1 indexed citations
2.
Qiao, Yun, Kaiyuan Hui, Chenxi Hu, et al.. (2025). Efficacy and safety of PD-1 blockade-activated neoantigen specific cellular therapy for advanced relapsed non-small cell lung cancer. Cancer Immunology Immunotherapy. 74(2). 60–60. 2 indexed citations
3.
Wang, Mei, et al.. (2025). Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β. Frontiers in Pharmacology. 16. 1497861–1497861. 3 indexed citations
4.
Wang, Mei, et al.. (2025). Circulating miR-4454 as a potential biomarker for the diagnosis of T2DM and the prediction value of comorbidity and complications in T2DM. BMC Endocrine Disorders. 25(1). 144–144. 1 indexed citations
5.
Wang, Mei, et al.. (2025). The potential of acupuncture in the treatment of Alzheimer's disease: An exploration from traditional Chinese medicine to modern technology. Complementary Therapies in Medicine. 93. 103222–103222. 1 indexed citations
6.
7.
Wang, Mei, et al.. (2024). Association of vitamin D receptor gene polymorphisms with caries risk in children: a systematic review and meta-analysis. BMC Pediatrics. 24(1). 650–650. 2 indexed citations
8.
Wang, Mei, et al.. (2024). Longevity of dental restorations in Sjogren’s disease patients using electronic dental and health record data. BMC Oral Health. 24(1). 203–203. 4 indexed citations
9.
Wang, Mei, et al.. (2024). Blood nesfatin-1 levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Frontiers in Endocrinology. 14. 1275753–1275753. 1 indexed citations
10.
Wang, Mei, et al.. (2024). Prediction of Sjögren’s disease diagnosis using matched electronic dental-health record data. BMC Medical Informatics and Decision Making. 24(1). 43–43. 1 indexed citations
11.
Wang, Mei, Ying Yin, Fei Xu, et al.. (2023). Neovascularization directed by CAVIN1/CCBE1/VEGFC confers TMZ-resistance in glioblastoma. Cancer Letters. 582. 216593–216593. 10 indexed citations
12.
Zhao, Hairong, Jiaming Lu, Furong He, et al.. (2022). Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation. Frontiers in Immunology. 13. 931087–931087. 14 indexed citations
13.
Zhao, Hairong, Mei Wang, Xiumei Wu, et al.. (2022). Wasp venom from Vespa magnifica acts as a neuroprotective agent to alleviate neuronal damage after stroke in rats. Pharmaceutical Biology. 60(1). 334–346. 11 indexed citations
14.
Li, Gang, Xinyu Gao, Jie Lei, et al.. (2022). Purification of biflavonoids from Selaginelladoe derleinii Hieron by special covalent organic polymers material. Journal of Chromatography A. 1668. 462920–462920. 5 indexed citations
15.
Wang, Mei, Xiaochun Jiang, Yongbo Yang, et al.. (2020). Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics. Neurotherapeutics. 17(4). 2028–2040. 16 indexed citations
16.
Zhang, Chengfei, Xiaoming Wang, Dan Fang, et al.. (2020). STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway. Theranostics. 11(5). 2108–2122. 29 indexed citations
17.
Wang, Mei & Xiaodong Jiang. (2018). The significance of SUMOylation of angiogenic factors in cancer progression. Cancer Biology & Therapy. 20(2). 130–137. 4 indexed citations
18.
Xu, Zhi, Yanyan Zhang, Jiaji Ding, et al.. (2018). miR-17-3p Downregulates Mitochondrial Antioxidant Enzymes and Enhances the Radiosensitivity of Prostate Cancer Cells. Molecular Therapy — Nucleic Acids. 13. 64–77. 61 indexed citations
19.
Wang, Mei, et al.. (2017). Intervention effect of yoga combined with music relaxation training on cancer related fatigue in breast cancer patients undergoing chemotherapy. Zhonghua xiandai huli zazhi. 23(2). 184–187. 6 indexed citations
20.
Jiang, Shan, Rongrong Zhu, Xiaolie He, et al.. (2016). Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles. International Journal of Nanomedicine. Volume 12. 167–178. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leye He Breakdown of academic impact, for papers by Wanfu Xu Breakdown of academic impact, for papers by Long Wang Breakdown of academic impact, for papers by Yih‐Jer Wu Breakdown of academic impact, for papers by Xinbo Wang Breakdown of academic impact, for papers by M. Yamashita
Rankless by CCL
2026